Yes, it's Trump's fault
The prosecution's case: Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness
The extreme prosecution of the sourced event.
Real event · international · 2026-11-10
The defense's case: Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness
Final verdict announced: November 11, 2026 at 5:01 PM ET
Satire
The extreme defense of the sourced event.
Real headline
Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness
The US FDA mandates that Ozempic and Wegovy include warnings about NAION.
Who took the documented action
See the original report.
Original reporting
Sources
-
BBC News — Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness — 2026-11-10
Original reporting. Open the source; this site does not replace it.
What the record shows
The FDA's order requires updated labeling for certain drugs.
Satirical commentary based on the sourced facts above. Not a news report, campaign, or endorsement.
The Result
Supporters might argue that the FDA's decision to mandate warnings about NAION on Ozempic and Wegovy is a testament to the government's commitment to patient safety. The defense submits that this proactive measure reflects a responsible approach to public health.
What Trump Did
The defense might suggest that under Trump's administration, there was a significant focus on addressing obesity through innovative treatments like GLP-1 drugs. The defense admits that while these drugs have been effective for many, the inclusion of warnings is a necessary step to ensure transparency.
Why Supporters Credit Him
Supporters might argue that the availability of these medications has empowered individuals to take control of their health, leading to better outcomes. The defense might argue that the FDA's actions are a recognition of the importance of monitoring drug safety.
The Supporting Record
The defense submits that the rise in popularity of these drugs has coincided with a national dialogue about obesity and health, which Trump helped to elevate.
The Limitation or Competing Explanation
However, the defense might argue that while the warnings are important, they should not overshadow the positive impact these drugs have had on many lives.
Verdict
If this is Trump's fault, his supporters will gladly let him take the blame.
Defense exhibits
Reality Check
The US Food and Drug Administration says Ozempic, Wegovy, and other weight-loss drugs must have labels about the condition, known as NAION.